Proton Pump Inhibitor Adverse Reaction

1

Review clinical trials related to Proton Pump Inhibitor Adverse Reaction. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Lactobacillus Reuteri Strain Combination in Children Treated With PPI

Probiotics might be of help in preventing dysbiosis and emergence of SIBO. Gastrus consisted of a mixture of two human strains of L. Reuteri DSM 17938 and ATCC PTA 6475; the first have extensive data supporting its use in gastric infections (18) however, it lacks the anti-inflammatory properties that have been provided by L. Reuteri DSM ATCC PTA 6475 that has excellent acid resistance and has strong anti-inflammatory properties (19); for these reasons, Gastrus is the best candidate for this indication.

Participants needed: 172
Trial details
Age: 12-14Biological sex: AllType: InterventionalSponsor: University of BariUpdated: Dec 5, 2024Locations: 1
Eligibility criteria

Age: children between 1 month and 14 years of age; [+2]

Neurological pathologies (PCI and Spastic tetra-paresis); [+7]